News Sentiment

IPH sentiment intelligence

Innate Pharma S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.61 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.9% over one week, -2.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Innate Pharma (Nasdaq: IPHA) outlines 2026 AGM quorum and key pipeline focus

Market Reaction

Balanced read

57/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 2.9% Price confirming higher
Trend fit Trend inactive -2.0% over four weeks
Fair value -18.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 3
Business Wire 2

Event Lens

What the news is about

Classified themes
Market update 4
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5